ClinicalTrials.govpublic full text
Erlotinib Prevention of Oral Cancer (EPOC)
oral cancer, oral ien lesion with loh, loss of heterozygosity, intraepithelial neoplasia, placebo, erlotinib, tarceva, osi-774, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874892
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.